|
Research article summary:
Double blind study of melatonin effects on the sleep-wake rhythm, cognitive and non-cognitive functions in Alzheimer type dementia.
Abstract Extract:
Previously, we reported that morning bright light therapy improved sleep time and cognitive function in Alzheimer type of dementia. We conducted a double blind study to examine the effects of melatonin on the sleep-wake rhythm, cognitive and ... (Full abstract text below) Published 2003Aug
in Journal: J Nippon Med Sch
(Language : eng)
Full Pubmed Extract
This information was retrieved, real-time, on your behalf from the public area of the Pubmed website:
1. J Nippon Med Sch.
2003 Aug;70(4):334-41
Double blind study of melatonin effects on the sleep-wake rhythm, cognitive and non-cognitive functions in Alzheimer type dementia.
Asayama K, Yamadera H, Ito T, Suzuki H, Kudo Y, Endo S
Department of Neuropsychiatry, Nippon Medical School, Tokyo, Japan. asayama@nms.ac.jp
Previously, we reported that morning bright light therapy improved sleep time and cognitive function in Alzheimer type of dementia. We conducted a double blind study to examine the effects of melatonin on the sleep-wake rhythm, cognitive and non-cognitive functions in Alzheimer type of dementia. The subjects were 9 persons given a placebo (PLA), and 11 given melatonin ( 3 mg)(MLT). The mean age was 79.2+/-6.4 (17 females and 3 males). The drugs were given at 20: 30 each day for 4 weeks. We checked sleep time and activity by Actigraph through one week before and the 4th week after drug administration. Cognitive and non-cognitive functions were evaluated with the clinical dementia rating scale (CDR), and Mini Mental State Examination (MMSE), and the Alzheimer's Disease Assessment Scale (ADAS). We successfully recorded Actigraph data from 18 patients (PLA8, MLT10). The mean sleep time change ratio and SD of the administration of PLA in the night was-0.2+/-13.7%, and MLT was 33.2+/-37.6%. The mean activity counts and SD of the administration of PLA in the night was 29.8+/-77.0%; in MLT it was-44.9+/-21.9%. Melatonin significantly prolonged the sleep time (p=0.017) and decreased activity (p=0.014) in the night (21: 00-6: 00) in the MLT group, although no significant difference in sleep time or activity in the daytime (6: 00-21: 00) was recognized between the two groups. In comparison with ADAS cognition score changes, the mean change and SD in the PLA was 0.3+/-3.7; in MLT it was-4.3+/-3.6 points. In comparison with ADAS non-cognition score, the mean change and SD in the PLA group was-0.8+/-1.0, in the MLT group it was-4.1+/-2.2 points. There were also significant differences between the PLA and the MLT groups in the comparison with the score improvement of ADAS cognition (p=0.017) and non-cognition (p=0.002), otherwise there was no significant difference in improvement of MMSE between both groups. Melatonin administration had effect to improve sleep time and night activity, but no significant effect to improve daytime naps and activity. Although melatonin administration might has less strong effect on circadian rhythm than morning bright light therapy we previously reported, cognitive and non-cognitive functions were improved. Melatonin seemed to be useful for care of the Alzheimer type of dementia patients.
PMID : 12928714 [PubMed - Indexed for MEDLINE]
This information is obtained from the National Library of Medicine (NLM). Abstract text and other information may be subject to copyright. Type "NLM copyright" into Google for more information.
Full Author Information
| First Name | LastName | Initials |
| Kentaro | Asayama | K |
| Hiroshi | Yamadera | H |
| Takao | Ito | T |
| Hideaki | Suzuki | H |
| Yoshihisa | Kudo | Y |
| Shunkichi | Endo | S |
Affiliation: Department of Neuropsychiatry, Nippon Medical School, Tokyo, Japan. asayama@nms.ac.jp
3rd Party provider links
Click the links below to go to related 3rd party information:
MESH categories and related page links
This article was linked to the MESH categories shown on the left below. The links on the right are related Memletics pages.
Category links from this article:- Aged
- Alzheimer Disease - physiopathology, psychology
- Circadian Rhythm - drug effects
- Cognition - drug effects
- Double-Blind Method
- Humans
- Male
- Melatonin - pharmacology
- Sleep - drug effects
- Wakefulness - drug effects
| | Related Memletics topics: |
Links for this articleFor links to places where you can get the full text of this article see links. Note there may be a subscription or fee required for access to the full text. New! Using similar technology to this site, we have launched find-health-articles.com, targeting over 1 million health research article abstracts. Related ArticlesHere are some articles related to this one (by title keywords): Keywords in this article:actigraph, activity, adas, administration, after, age, alzheimer, assessment, blind, bright, care, cdr, change, changes, checked, circadian, clinical, cognition, cognitive, comparison, conducted, counts, data, day, daytime, decreased, dementia, difference, differences, disease, double, drugs, effects, evaluated, examination, examine, females, function, functions, given, group, groups, improved, improvement, less, light, mean, melatonin, mental, mlt, mmse, morning, naps, night, non, one, otherwise, p=, patients, persons, placebo, points, previously, prolonged, rating, recognized, recorded, reported, rhythm, scale, score, sd, seemed, significant, sleep, state, strong, study, subjects, successfully, therapy, time, two, type, useful, wake, weeks
|
